Coronary heart disease
Conditions
Interventions
Treatment group:Conventional western medicine + Chai Hu Gui Zhi Tang granules
Control group:Conventional western medicine+Placebo granules
Sponsors
Yueyang Hospital of Integrative Medicine, Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1 Meet the diagnostic criteria for stable angina pectoris in coronary heart disease. 2 Meeting the diagnostic criteria of TCM chest paralysis - Qi stagnation in the heart and chest. 3 Subjects were between the ages of 40 and 80 years, including 40 and 80 years, with no restriction on gender. 4 Subjects gave informed consent to participate in this study, signed an informed notification form and were able to cooperate with the treatment
Exclusion criteria
Exclusion criteria: 1 Those with confirmed acute myocardial infarction (including necrotic Q-wave and non-necrotic Q-wave types), unstable angina pectoris, and chest pain due to e.g. hyperthyroidism, menopausal syndrome, biliary heart disease, neurosis, gastric and esophageal reflux, neuritis, trauma, etc. 2 with factors such as severe heart failure, cardiogenic shock, severe ventricular arrhythmias, obstructive or dilated cardiomyopathy, pericardial tamponade, severe hemodynamically unstable heart valve disease, pulmonary embolism, uncontrollable hypertension, and severe infections. 3 Patients who meet the diagnostic criteria for stable angina pectoris in coronary artery disease but are not routinely treated according to the relevant guidelines. 4 Patients with serious combined diseases of the liver, kidney, hematopoietic system and endocrine system. 5 Patients with psychiatric abnormalities and unwillingness to cooperate 6 Pregnant or lactating women or women with childbearing requirements 7 Allergy or multiple drug allergy. 8 Other conditions deemed by the investigator to be unsuitable for participation in this trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Angina pectoris treatment effect;Chinese medicine evidence of efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Nitroglycerin discontinuation reduction rate;Resting ECG Efficacy;Seattle Angina Scale;Blood lipids;Vascular endothelial diastolic function index; | — |
Countries
China
Contacts
Public ContactShen Yan
Outcome results
None listed